About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
HISTORICAL VOLUME
Historical
Volume
Piramal Pharma Ltd.
BSE Code
543635
ISIN Demat
INE0DK501011
Book Value
56.48
NSE Code
PPLPHARMA
Dividend Yield %
0.07
Market Cap
270701.38
P/E
37.64
EPS
5.41
Face Value
10
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Date
Open Price(Rs.)
High Price(Rs.)
Low Price(Rs.)
Close Price(Rs.)
Volume
Turnover
21-Oct-2025
195.65
198.40
195.60
197.10
70352
13831102
20-Oct-2025
193.25
196.15
191.65
195.35
636508
123291000
17-Oct-2025
194.25
195.20
191.15
192.65
278344
53959948
16-Oct-2025
193.60
195.35
193.25
194.30
119917
23338366
15-Oct-2025
192.65
194.80
191.60
193.55
333813
64377078
14-Oct-2025
197.60
197.95
190.80
192.35
246549
47633484
13-Oct-2025
201.70
201.75
197.00
197.60
166146
33122575
10-Oct-2025
197.65
206.50
195.50
201.75
363026
73756465
09-Oct-2025
193.75
198.80
193.75
197.65
134469
26557072
08-Oct-2025
194.95
197.75
193.25
193.70
49954
9744318
07-Oct-2025
196.15
197.95
193.75
195.55
57825
11315376
06-Oct-2025
198.70
199.00
193.80
195.45
126818
24848697
03-Oct-2025
199.25
201.50
196.20
198.50
118930
23623393
01-Oct-2025
190.85
200.20
190.85
199.30
316480
62007358
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.